Randomized phase II trial of uracil/tegafur and cisplatin versus pemetrexed and cisplatin with concurrent thoracic radiotherapy for locally advanced unresectable stage III non-squamous non-small cell lung cancer: NJLCG1001

BACKGROUND: The optimal regimen for concurrent chemoradiotherapy (CCRT) of locally advanced non-squamous non-small cell lung cancer (NSCLC) was not definitive. We conducted randomized phase II study, NJLCG0601, and chemoradiotherapy with uracil/tegafur (UFT) and cisplatin achieved promising efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Watanabe, Kana, Toi, Yukihiro, Nakamura, Atsushi, Chiba, Ryosuke, Akiyama, Masachika, Sakakibara-Konishi, Jun, Tanaka, Hisashi, Yoshimura, Naruo, Miyauchi, Eisaku, Nakagawa, Taku, Igusa, Ryotaro, Minemura, Hiroyuki, Mori, Yoshiaki, Fujimoto, Keisuke, Matsushita, Haruo, Takahashi, Fumiaki, Fukuhara, Tatsuro, Inoue, Akira, Sugawara, Shunichi, Maemondo, Makoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947416/
https://www.ncbi.nlm.nih.gov/pubmed/33718016
http://dx.doi.org/10.21037/tlcr-20-721

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947416/
https://www.ncbi.nlm.nih.gov/pubmed/33718016
http://dx.doi.org/10.21037/tlcr-20-721

Ejemplares similares